|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giacinti L, Claudio PP, Lopez M and
Giordano A: Epigenetic information and estrogen receptor alpha
expression in breast cancer. Oncologist. 11:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cuzick J, Sestak I, Baum M, Buzdar A,
Howell A, Dowsett M and Forbes JF: ATAC/LATTE investigators: Effect
of anastrozole and tamoxifen as adjuvant treatment for early-stage
breast cancer: 10-year analysis of the atac trial. Lancet Oncol.
11:1135–1141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martínez-Galán J, Torres-Torres B, Núñez
MI, López-Peñalver J, Del Moral R, De Almodóvar Ruiz JM, Menjón S,
Concha A, Chamorro C, Ríos S and Delgado JR: Esr1 gene promoter
region methylation in free circulating DNA and its correlation with
estrogen receptor protein expression in tumor tissue in breast
cancer patients. BMC Cancer. 14:592014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yahya SM and Elsayed GH: A summary for
molecular regulations of miRNAs in breast cancer. Clin Biochem.
48:388–396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan L, Nass SJ, Smith D, Nelson WG, Herman
JG and Davidson NE: Specific inhibition of DNMT1 by antisense
oligonucleotides induces re-expression of estrogen receptor-alpha
(ER) in ER-negative human breast cancer cell lines. Cancer Biol
Ther. 2:552–556. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y,
Qi YT, Li W, Lu B, Peiper SS, et al: A regulatory circuit of
mir-148a/152 and DNMT1 in modulating cell transformation and tumor
angiogenesis through IGF-IR and IRS1. J Mol Cell Biol. 5:3–13.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang B, Warner M and Gustafsson JÅ:
Estrogen receptors in breast carcinogenesis and endocrine therapy.
Mol Cell Endocrinol 418 Pt. 3:240–244. 2015. View Article : Google Scholar
|
|
12
|
Shoker BS, Jarvis C, Clarke RB, Anderson
E, Hewlett J, Davies MP, Sibson DR and Sloane JP: Estrogen
receptor-positive proliferating cells in the normal and
precancerous breast. Am J Pathol. 155:1811–1815. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Liu R, Fu P, Du F, Hong Y, Yao M,
Zhang X and Zheng S: N1-guanyl-1,7-diaminoheptane sensitizes
estrogen receptor negative breast cancer cells to doxorubicin by
preventing epithelial-mesenchymal transition through inhibition of
eukaryotic translation initiation factor 5A2 activation. Cell
Physiol Biochem. 36:2494–2503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Souza Rocha, Simonini P, Breiling A,
Gupta N, Malekpour M, Youns M, Omranipour R, Malekpour F, Volinia
S, Croce CM, Najmabadi H, et al: Epigenetically deregulated
microRNA-375 is involved in a positive feedback loop with estrogen
receptor alpha in breast cancer cells. Cancer Res. 70:9175–9184.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang YS, Chou WW, Chen KC, Cheng HY, Lin
RT and Juo SH: MicroRNA-152 mediates DNMT1-regulated DNA
methylation in the estrogen receptor α gene. PLoS One.
7:e306352012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Song YX and Wang ZN: The
microRNA-148/152 family: Multi-faceted players. Mol Cancer.
12:432013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Razin A and Szyf M: DNA methylation
patterns. Formation and function. Biochim Biophys Acta.
782:331–342. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szyf M: DNA methylation signatures for
breast cancer classification and prognosis. Genome Med. 4:262012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan PS, Perry MR, Laux DE, Asare AL,
Caldwell CW and Huang TH: CpG island arrays: An application toward
deciphering epigenetic signatures of breast cancer. Clin Cancer
Res. 6:1432–1438. 2000.PubMed/NCBI
|
|
20
|
Li E, Bestor TH and Jaenisch R: Targeted
mutation of the DNA methyltransferase gene results in embryonic
lethality. Cell. 69:915–926. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen KC, Wang YS, Hu CY, Chang WC, Liao
YC, Dai CY and Juo SH: OxLDL up-regulates microRNA-29b, leading to
epigenetic modifications of MMP-2/MMP-9 genes: A novel mechanism
for cardiovascular diseases. FASEB J. 25:1718–1728. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang J, Wang Y, Guo Y and Sun S:
Down-regulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Braconi C, Huang N and Patel T:
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor
suppressor gene expression by interleukin-6 in human malignant
cholangiocytes. Hepatology. 51:881–890. 2010.PubMed/NCBI
|
|
24
|
Rakha EA, El-Sayed ME, Green AR, Lee AH,
Robertson JF and Ellis IO: Prognostic markers in triple-negative
breast cancer. Cancer. 109:25–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anders CK and Carey LA: Biology,
metastatic patterns, and treatment of patients with triple-negative
breast cancer. Clin Breast Cancer. 9 Suppl 2:S73–S81. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tomao F, Papa A, Zaccarelli E, Rossi L,
Caruso D, Minozzi M, Vici P, Frati L and Tomao S: Triple-negative
breast cancer: New perspectives for targeted therapies. Onco
Targets Ther. 8:177–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
